HUE026628T2 - Tasakos kiszerelés amin polimerekhez - Google Patents

Tasakos kiszerelés amin polimerekhez Download PDF

Info

Publication number
HUE026628T2
HUE026628T2 HUE06824928A HUE06824928A HUE026628T2 HU E026628 T2 HUE026628 T2 HU E026628T2 HU E06824928 A HUE06824928 A HU E06824928A HU E06824928 A HUE06824928 A HU E06824928A HU E026628 T2 HUE026628 T2 HU E026628T2
Authority
HU
Hungary
Prior art keywords
powder
polymer
carbonate
pharmaceutically acceptable
container
Prior art date
Application number
HUE06824928A
Other languages
English (en)
Inventor
Hitesh R Bhagat
Jeffrey M Goldberg
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37873217&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE026628(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of HUE026628T2 publication Critical patent/HUE026628T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/896Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Claims (5)

  1. Szabadalmi igénypontok }. Bgy |p>gyásxati!ag a&g? porkészitmény; amely tartalmaz: m egy M szénatümos algiaát Ä^sÄ^soportot vagy egy 3~S ezénatomos alglnát mioi-éSrter cssmötfot tartalmazó. g> ogyászatilag elfogható anlonos polimer stabilizáfoszert; b) egy gyógyászatilag atóiy alifás políáilslamm polimert egy kétfohkciós térhálósítószerM térhálósává, vagy egy gyogyaÄhäg elfőgádhaio sóját az anlortos polimer smbillzálószerref vegyítve, azzal jellemezve, hogy a tédtálös polimer sevefa-mer karbonátos sdja,: % Az 1. igénypont ::8Ζ®«1Ι pif* ahol m aníonos pointer stabliizálószer ebléngtlkof-algmál piOpilèngükol-algâiâéés glíeería-algibaí körébil valapipis, 3v kû I, vagy 2. igénypont szerinti por, ahol a prta lévő egyetlen gyógyászati lag aktív összetevő « sevelameokarbonát. 4* Ä' előző igénypontok bármelyike szerinti par, api az anionos polimer siabMMlószer propílénglikolmlginát. 5:. Az előző- igánypitök -Äwlf jfce szetmll pr> amely tartalmaz továbbá egy győgyászatiiag dfogaŐkaió édesitiszeíi, amely legalább egyet tartalmaz sznkraióz, szacharóz, xilóz, maarát maiit,: maitól, szerbit és xlftt köriből választva,
  2. 6. Az előző ígénypontők bármelyiké szerinti pb ahol a por tartalmaz továbbá egy gyógyászátiíag elfogadható, egy vegyertékö, szervetlen hátfinm-kíondot tartalmazó áalóhfoiTásL ?> Az előzi igénypontok bármelyike szerinti por, ahol a por tartalmaz továbbá sásga vasoxidot. I:. Az előző .igénypontok bármelyike saer|p:| pop aboi a por tartalmaz továbbá egy gyögyászattlag; éítbgad ha tó i zes kőanyagot. #; Az előző igénypontok bármelyike: szerintt pop Pol a por tartalmaz továbbá citrom Ízesítést tartalmazó ízesitőaoyagok Itt Az előző igénypontok bármely ike szerinti pop, ahol a; por nem : kapszulázott és spbmion fölyik, és kevesebb mint S tömeg% 3ÍM) tóteöméM»# részecskét ős kevesebb mint S tömeg% lő mikrométernél jmltapnál| kisebb részecskeméreté részecskéi tartalmaz. 11 > Az előző igénypontok bármely ike szerinti por, ahol a por egy tárolóeszközbe: csomagolt, amely aj tasak, vagy b) légek 12, A 12. Igénypont szerinti por, Âoî a tárolóeszköz lmg-15 g seyeíámet^rbösáíot tartalmaz. a seyelamer karbonát mennyisége egy vízmentes bázison található,: :13-. & IL igénypont szerinti por, atel a por tartalmaz: a| SOO mg vagy 2,4 g sevelamer tetenáiöt egy vízmentes bázison; és 1?) ax atbonos polimer sttelli2álész^píl)piÍéss|LI;oLalgsnáí; atel a porban m egyetlen gyógyászati teértoyag a sevelamer karbonát, és ahol a propilépglíkol-algioát aránya a sevelamer karbonátez &Í0S-1 : I. 14:. A 1L igénypont szerinti por, atel a tárolóeszköz egy tasak.
  3. 15. Az L igénypont érinti- pof, ahol a gyogyászatiiag elfogadható mim®* polimer sÄlh^löszer pippilénglikol alginát, a gyogyászatiiag aktiv aillas Összetevő sevelánrer karbonát ás adott eseten a por tartalmaz továbbá egy vagy Äh összetevőt az alábbiak kÖÄöl választva: a) egy vegyértékű, szervetlen nátriam-klorldat tartalmazó anÎoÂrrâs; b) naranes, vanília es dirons izeket tartalmazó ízesítőszer; c) sztíkmkrtí tartalmazó édesítőszerek; d) sárga vasoxidot tartalmazó színezékek. 1-4 Az előap igénypernek bármelyike szerinti port tartalmazó gyógyászokig aktív: folyadék vagy por készítmények iszeselés, hiperfesxlatésníáten saenvedő egyén kezelésében való alkalmazásra, hatásos t&epayiség orális beadásával az egyén részére, I ?:, A lé, igénypont szerinti készítmény, ahol a készítmény égy az 1~1J, igénypontok hárntelyike szerlnll port (fofoldyaVagy szuszpendálva tartalntazó folyékosty készhméoy:
  4. 18. Az 1-10. vágy M> igénypontok bármelyike szerinti por! tartalmazó tárolóeszköz.
  5. 19. Az 1-10. vagy 15. igénypontok bármelyike szerinti port tartalmazd tasak, 20. A 19. igénypont szerinti tasak, ahol a por 800 mg sevelamer karbonátot tartalmaz egy vízmentes bázison. :2:3:. A if, If^nypotrt samlittt iassi, ®W a gyógyii^tiag: elfogadbâtô anlonoS: polimer rtabilizálos^r prop! léngffai aíginát. 22, Ä 23, igénypont szerinti tasak, ahol a propilénglikol-algmát aránya a sevelamer karbonáthoz (),005-1:1. 23. A 21, igénypont szerinti tasak, ahol a por tariahnsz továbbá egy vagy több összetevőt az alábbiak köréből választva: á) egy vsgyértéki, szervetlen náíriorn-kloridot tartalmazó ániónfotrás; b) narancs, vanília és diront izeket tartalmazó ízesítőszer; ő) szakrÄd tartalma® édésteszeréfc; d) sárga vasoxidoí tartalmazó színezékek.
HUE06824928A 2005-09-15 2006-09-12 Tasakos kiszerelés amin polimerekhez HUE026628T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71720005P 2005-09-15 2005-09-15

Publications (1)

Publication Number Publication Date
HUE026628T2 true HUE026628T2 (hu) 2016-06-28

Family

ID=37873217

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE06824928A HUE026628T2 (hu) 2005-09-15 2006-09-12 Tasakos kiszerelés amin polimerekhez

Country Status (18)

Country Link
US (4) US9095509B2 (hu)
EP (2) EP3000460A1 (hu)
JP (3) JP5595660B2 (hu)
KR (2) KR101574072B1 (hu)
CN (2) CN103027896B (hu)
AU (1) AU2006292672B2 (hu)
BR (1) BRPI0616078B8 (hu)
CA (1) CA2622693C (hu)
DK (1) DK1924246T3 (hu)
ES (1) ES2556217T3 (hu)
HK (2) HK1111893A1 (hu)
HU (1) HUE026628T2 (hu)
IL (3) IL189967A (hu)
NZ (1) NZ566542A (hu)
PL (1) PL1924246T3 (hu)
PT (1) PT1924246E (hu)
SI (1) SI1924246T1 (hu)
WO (1) WO2007035313A2 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2009507019A (ja) * 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
KR101574072B1 (ko) 2005-09-15 2015-12-04 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
JP2009536246A (ja) * 2006-05-05 2009-10-08 ゲンズイメ コーポレーション ホスフェート捕捉剤としてのアミン縮合重合体
CA2658338A1 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
WO2008076242A1 (en) * 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
US20100196305A1 (en) * 2007-03-08 2010-08-05 Dhal Pradeep K Sulfone polymer compositions
WO2008133954A1 (en) * 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
PA8807201A1 (es) * 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009078958A1 (en) * 2007-12-14 2009-06-25 Genzyme Corporation Coated pharmaceutical compositions
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
WO2010022380A2 (en) * 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
WO2013064193A1 (en) 2011-11-04 2013-05-10 Synthon Bv Pharmaceutical compositions comprising sevelamer
CN102895204B (zh) * 2012-11-08 2014-12-31 南京生命能科技开发有限公司 一种用于制备片剂的碳酸司维拉姆原料药及其制备方法和应用
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用
WO2020138921A1 (ko) * 2018-12-24 2020-07-02 동인당제약 주식회사 세벨라머 함유 경구투여용 현탁제 조성물 및 그 제조방법
KR102281492B1 (ko) 2018-12-24 2021-07-26 동인당제약 주식회사 세벨라머 함유 경구투여용 현탁제 조성물 및 그 제조방법
WO2023149581A1 (ja) * 2022-02-06 2023-08-10 豊光社テクノロジーズ株式会社 表面処理液、表面処理樹脂及び樹脂フィルム積層体の製造方法
JP7120695B1 (ja) 2022-02-06 2022-08-17 豊光社テクノロジーズ株式会社 樹脂フィルム積層体とその製造方法、及び金属被覆樹脂の製造方法
EP4295836A1 (en) 2022-06-22 2023-12-27 Labomed Pharmaceutical Company S.A. Sachet comprising a liquid suspension of a sevelamer salt

Family Cites Families (213)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2426125A (en) * 1944-04-03 1947-08-19 Kelco Co Manufacture of glycol alginates
US2456428A (en) 1944-10-11 1948-12-14 Shell Dev Polyallyl amine and related polymeric amines
US2463824A (en) * 1947-08-02 1949-03-08 Kelco Co Substituted alkylene glycol esters of alginic acid
BE580490A (fr) 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3104205A (en) 1959-12-17 1963-09-17 Warner Lambert Pharmaceutical Deodorant composition comprising the copper complex of the copolymer of allylamine and methacrylic acid
US3308020A (en) 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3332841A (en) 1961-10-04 1967-07-25 Lilly Co Eli Method of treating hyperacidity
US3142621A (en) 1961-11-02 1964-07-28 Ciba Geigy Corp Alginate suspensions of oral pharmaceutical compositions with improved taste qualities
US3383236A (en) 1964-04-17 1968-05-14 Merck & Co Inc Continuous pharmaceutical film coating process
US3624209A (en) 1966-12-28 1971-11-30 Bristol Myers Co Composition for treatment of gastro-intestinal disorders
GB1181003A (en) 1967-03-20 1970-02-11 Mead Johnson & Co Therapeutic Compositions
US3431138A (en) 1967-07-14 1969-03-04 American Cyanamid Co Method for coating pharmaceutical forms with methyl cellulose
US3539380A (en) 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
DE1927336A1 (de) 1968-06-17 1969-12-18 Upjohn Co Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie
US3980770A (en) 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
CH604722A5 (hu) 1973-02-09 1978-09-15 Sandoz Ag
AR206115A1 (es) 1973-06-11 1976-06-30 Merck & Co Inc Procedimiento para preparar un polimero lineal no ramificado y no reticulado
US4205064A (en) 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
US4016209A (en) 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof
US4181718A (en) 1975-12-29 1980-01-01 Mason Norbert S Polyanion-stabilized aluminum hydrogels
US4071478A (en) 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
US4115537A (en) 1976-09-07 1978-09-19 American Hospital Supply Corporation Resin tablet and use thereof in diagnostic tests
US4183918A (en) 1977-03-08 1980-01-15 Exxon Research & Engineering Co. Detoxifying-medicinal emulsions
GB1566609A (en) * 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
GB1573487A (en) 1977-05-23 1980-08-28 Bristol Myers Co Bile acid binding composition
US4211763A (en) 1977-08-08 1980-07-08 The Dow Chemical Company Anion exchange resin in the determination of thyroid function
US4143130A (en) 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS5566513A (en) 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
US4341563A (en) 1978-11-17 1982-07-27 Sankyo Company Limited Protective coating compositions
US4247393A (en) 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
US4264573A (en) 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4439419A (en) 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4302440B1 (en) 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4344993A (en) 1980-09-02 1982-08-17 The Dow Chemical Company Perfluorocarbon-polymeric coatings having low critical surface tensions
DE3169753D1 (en) 1980-12-12 1985-05-09 Smith & Nephew Ass Polymers, preparation and use
JPS5879022A (ja) 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US4504640A (en) 1982-05-19 1985-03-12 Nitto Boseki Co., Ltd. Process for producing monoallylamine polymer
EP0211991B1 (en) 1982-07-08 1989-10-25 Ab Leo Substained release tablets and method for preparation thereof
US4518433A (en) 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4539198A (en) 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
CA1220896A (en) 1983-11-10 1987-04-21 Susumu Harada Process for producing polymers of monoallylamine
JPS60152424A (ja) 1984-01-18 1985-08-10 Daicel Chem Ind Ltd 固形製剤
DE3572985D1 (en) 1984-05-11 1989-10-19 Bristol Myers Co Novel bile sequestrant resin and uses
US4688988A (en) 1984-12-17 1987-08-25 United Technologies Corporation Coolable stator assembly for a gas turbine engine
US4631305A (en) 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
DE3541511A1 (de) 1985-11-19 1987-05-21 Grace W R Ab Promoter fuer die papierleimung, verfahren zu dessen herstellung und dessen verwendung
US4871779A (en) 1985-12-23 1989-10-03 The Dow Chemical Company Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities
CH656535A5 (en) 1986-01-24 1986-07-15 Spirig Ag Process for the production of stable pharmaceutical tablets which disintegrate rapidly in water
JPS62132830U (hu) 1986-02-18 1987-08-21
US4849227A (en) 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
IT1190349B (it) 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5310572A (en) 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US4762524A (en) 1987-02-05 1988-08-09 Hoechst Celanese Corporation Composition comprising the addition product of a vinyl-sulfone dye and a secondary amine and process for dyeing a polyamide therewith
US5073380A (en) 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4983398A (en) 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
US4853437A (en) 1988-03-04 1989-08-01 Hercules Incorporated Water- and caustic-insoluble, inswellable, fibrous, particulate crosslinked polymer
US5520932A (en) 1988-06-24 1996-05-28 The Upjohn Company Fine-milled colestipol hydrochloride
US5807582A (en) 1988-08-26 1998-09-15 Pharmacia & Upjohn Company Fine-beaded colestipol hydrochloride and pharmaceutically elegant dosage forms made therefrom
EP0429541B1 (en) 1988-08-26 1993-12-01 The Upjohn Company Fine-beaded colestipol hydrochloride
US5194464A (en) 1988-09-27 1993-03-16 Takeda Chemical Industries, Ltd. Enteric film and preparatoin thereof
GB8829835D0 (en) 1988-12-21 1989-02-15 Smith Kline French Lab Compounds
DE3901527A1 (de) 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5372823A (en) 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US4956182A (en) 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
US6274713B1 (en) 1989-04-07 2001-08-14 Salutar, Inc. Polychelants
US5236701A (en) 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
US4983399A (en) 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US5053423A (en) 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
JPH0687974B2 (ja) 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
DE4010271A1 (de) 1990-03-30 1991-10-02 Basf Ag Verfahren zur herstellung von ethylenpolymerisaten bei druecken oberhalb von 500 bar in einem rohrreaktor mit einspritzfinger
IE914179A1 (en) 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
US5262167A (en) 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
US5055197A (en) 1991-04-05 1991-10-08 Rohm And Haas Company Process for removing residual monomers and oligemers from amine-containing polymers
US5108767A (en) 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
ES2124736T3 (es) 1991-07-03 1999-02-16 Upjohn Co Comprimidos con alto contenido de clorhidrato de colestipol.
US5840339A (en) 1991-07-30 1998-11-24 Kunin; Robert Blood cholesterol reducing pharmaceutical composition
JP2785529B2 (ja) 1991-08-21 1998-08-13 日東紡績株式会社 エタノール徐放剤およびそれを用いた食品保存用組成物
EP0534304A1 (de) 1991-09-21 1993-03-31 Hoechst Aktiengesellschaft Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika
SE470006B (sv) 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
JPH05170845A (ja) 1991-12-20 1993-07-09 Nippon Paint Co Ltd 有機ポリマー微粒子およびその製法
US5610268A (en) 1992-01-13 1997-03-11 Dsm N.V. Dendritic macromolecule and the preparation thereof
US5530092A (en) 1992-01-13 1996-06-25 Dsm N.V. Dendritic macromolecule and the preparation thereof
US5654003A (en) 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
EP0580078B1 (de) 1992-07-22 1997-10-15 Hoechst Aktiengesellschaft Hydrophile Zentren aufweisende Polyvinylamin-Derivate, Verfahren zu ihrer Herstellung sowie die Verwendung der Verbindungen als Arzneimittel, Wirkstoffträger und Nahrungsmittelhilfsstoff
EP0580079B1 (de) 1992-07-22 1996-12-11 Hoechst Aktiengesellschaft Vernetzte, stickstoffhaltige Vinylcopolymere, Verfahren zu ihrer Herstellung sowie die Verwendung dieser Verbindungen
WO1994004596A1 (en) 1992-08-20 1994-03-03 E.I. Du Pont De Nemours And Company Crosslinked polymeric ammonium salts
US5302531A (en) 1992-10-22 1994-04-12 Miles Inc. Composition for the semiquantitative determination of specific gravity of a test sample
EP0605757B1 (en) 1992-11-25 2001-08-16 Ajinomoto Co., Inc. Compositions and goods containing minerals and poly-gamma-glutamic acid
EP0684958B1 (en) 1993-02-17 1998-06-10 Btg International Limited Polymers containing guanidino groups for use in therapy
US5376396A (en) 1993-04-27 1994-12-27 Merck & Co., Inc. Beverage stabilizing system and process thereof
JPH06321786A (ja) 1993-05-12 1994-11-22 Sekisui Chem Co Ltd 胆汁酸腸管吸収抑制剤
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5900475A (en) 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
WO1994027620A1 (en) 1993-06-02 1994-12-08 Geltex Pharmaceuticals, Inc. Compositions and process for removing bile salts
US5618530A (en) 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
CA2129079C (en) 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JPH09506342A (ja) 1993-11-25 1997-06-24 サルテルナテ・ベー・ブイ 一価カチオンに結合する粒子、並びにナトリウムおよび/またはカリウムイオンを捕捉して除去するための上記粒子の使用および方法
US5414068A (en) 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
AUPM623994A0 (en) 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
JP3355593B2 (ja) 1994-08-19 2002-12-09 信越化学工業株式会社 固形腸溶製剤の製造方法
WO1996021454A1 (en) 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
GB9503061D0 (en) 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
JP2936129B2 (ja) 1995-04-12 1999-08-23 セイコー精機株式会社 防食構造
US5686106A (en) 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5561214A (en) 1995-05-18 1996-10-01 Bayer Corporation Hyperbranched polyaspartate esters and a process for their preparation
US5709880A (en) 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers
TW438608B (en) 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
GB2308363A (en) 1995-12-22 1997-06-25 Courtaulds Coatings Dendritic Polymers
FI104823B (fi) 1996-06-24 2000-04-14 Borealis Polymers Oy Likaantumista estävä päällyste
US6034129A (en) 1996-06-24 2000-03-07 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US5747067A (en) 1996-12-06 1998-05-05 Fmc Corporation Co-processed products
DE19654179A1 (de) 1996-12-23 1998-06-25 Basf Ag H-förmige Polyamide
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
AU2446497A (en) 1997-03-25 1998-10-20 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers combined with a calcium supplement for oral administration
US5925379A (en) 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
JP3389493B2 (ja) 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JPH10316576A (ja) 1997-05-13 1998-12-02 Nissui Pharm Co Ltd キトサン含有錠剤
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6730735B2 (en) * 1997-07-03 2004-05-04 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Conjugate of polyethylene glycol and chitosan
DE69834255T2 (de) 1997-07-25 2006-09-28 Alpex Pharma S.A. Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
US6187897B1 (en) 1997-09-01 2001-02-13 Toyo Ink Manufacturing Co., Ltd. Vinyl-group-containing dendrimer and curable composition
US6290947B1 (en) 1997-09-19 2001-09-18 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin-binding agents
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6264937B1 (en) 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6090411A (en) 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
DE19835467A1 (de) 1998-08-06 2000-02-17 Elenac Gmbh Feststoffreaktor mit antistatischer Beschichtung zur Durchführung von Reaktionen in der Gasphase
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
TW568788B (en) 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
JP2000178182A (ja) 1998-12-17 2000-06-27 Lion Corp 崩壊性組成物
US6362266B1 (en) 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
JP2001072576A (ja) 1999-09-03 2001-03-21 Kissei Pharmaceut Co Ltd 経口用医薬品組成物
US6180754B1 (en) 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
CA2385749A1 (en) 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
ATE286386T1 (de) * 1999-10-19 2005-01-15 Genzyme Corp Direktkomprimierter tablettenkern auf polymerbasis
WO2001066607A1 (fr) 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
WO2001068106A1 (fr) 2000-03-13 2001-09-20 Hisamitsu Pharmaceutical Co., Inc. Prophylactiques et/ou remedes pour hyperphosphatemie
CN1261094C (zh) * 2000-07-28 2006-06-28 霍夫曼-拉罗奇有限公司 脂肪酶抑制剂的新用途
DE60132256T2 (de) 2000-11-20 2008-12-24 Sorbent Therapeutics, Inc., Vernon Hills Wasserabsorbierende polymere und deren verwendung
US20030175349A1 (en) 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US6534600B2 (en) 2001-03-26 2003-03-18 Michigan Molecular Institute Hyperbranched polyureas, polyurethanes, polyamidoamines, polyamides and polyesters
BR0209124A (pt) 2001-04-18 2005-02-09 Genzyme Corp Método para tratar uma sìndrome x ou inibir o inìcio dos sintomas da sìndrome x e uso de uma quantidade terapeuticamente efetiva de um sal de pelo menos um polìmero de amina alifática
WO2002085380A1 (en) 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
JP2004528332A (ja) 2001-04-18 2004-09-16 ジェンザイム コーポレーション 痛風を治療する方法および尿酸を結合する方法
KR20040018357A (ko) 2001-04-18 2004-03-03 젠자임 코포레이션 저염 형태의 폴리알릴아민
AU2002257145B2 (en) 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
WO2002085383A1 (en) 2001-04-18 2002-10-31 Genzyme Corporation Method for reducing copper levels and treating copper toxicosis
WO2002085379A1 (en) 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
WO2003002071A2 (en) * 2001-06-29 2003-01-09 Lewandowski Leon J Individualized addiction cessation therapy
CN1270724C (zh) 2001-07-30 2006-08-23 三菱制药株式会社 餐后高血糖改善剂
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
US7815936B2 (en) 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
DE10163163A1 (de) 2001-12-20 2003-07-03 Basf Ag Verfahren zur Herstellung hochfunktioneller, Hyperverzweigter Polyester durch enzymatische Veresterung
US7208314B2 (en) 2002-02-26 2007-04-24 Mirus Bio Corporation Compositions and methods for drug delivery using pH sensitive molecules
US20030161875A1 (en) 2002-02-27 2003-08-28 Deepak Murpani Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
US7109184B2 (en) * 2002-03-19 2006-09-19 Genzyme Corporation Phosphate transport inhibitors
US20030180250A1 (en) 2002-03-22 2003-09-25 Council Of Scientific And Industrial Research Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents
US7169450B2 (en) * 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US20040161474A1 (en) 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
ITMI20021718A1 (it) 2002-07-31 2004-02-01 Sematic Italia Spa Interruttore di sicurezza con sistema elettronico programmabile.
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
DE10250711A1 (de) 2002-10-31 2004-05-19 Degussa Ag Pharmazeutische und kosmetische Zubereitungen
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
WO2004099288A1 (en) 2003-05-09 2004-11-18 Carlsberg A/S Polyethyleneimine polymers
TW200507882A (en) 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
WO2005021000A1 (en) 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US20050208095A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
US7309500B2 (en) 2003-12-04 2007-12-18 The Board Of Trustees Of The University Of Illinois Microparticles
EP1699442A2 (en) * 2003-12-31 2006-09-13 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
WO2005072752A1 (ja) * 2004-01-30 2005-08-11 Taisho Pharmaceutical Co., Ltd. 高リン血症の予防又は治療剤
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
KR20050104152A (ko) 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
DK2258349T3 (da) * 2004-05-11 2014-10-13 Egalet Ltd Kvældbar doseringsform omfattende gellangummi
US7973122B2 (en) 2004-06-17 2011-07-05 General Cable Technologies Corporation Polyamideimide compositions having multifunctional core structures
JP4845353B2 (ja) * 2004-06-29 2011-12-28 田辺三菱製薬株式会社 陰イオン交換樹脂を含む医薬組成物
US20060024368A1 (en) 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US7218130B2 (en) 2004-08-25 2007-05-15 Micron Technology, Inc. Bottom side stiffener probe card
US7019085B2 (en) 2004-08-30 2006-03-28 Albright Robert L Phosphate selective resin and related methods
TWM271254U (en) 2004-09-10 2005-07-21 Sen Tech Co Ltd Heat dissipation base and package structure for light-emitting diode
CA2583548A1 (en) 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
CA2601236A1 (en) 2005-03-16 2006-09-21 Usv Limited An improved process for the preparation of crosslinked polyallylamine polymer
DE102005037632A1 (de) 2005-08-09 2007-02-15 Hilti Ag Wanddetektor
CA2622021C (en) 2005-09-14 2014-07-15 Wisconsin Alumni Research Foundation Composition comprising a dendrimer and the use thereof for binding phosphate
KR101574072B1 (ko) 2005-09-15 2015-12-04 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
US20070094779A1 (en) 2005-10-31 2007-05-03 Dauphin Joseph A Three piece toilet maintenance kit
US20070110707A1 (en) 2005-11-04 2007-05-17 Washington University Method of treating diseases involving non-enzymatic glycation

Also Published As

Publication number Publication date
KR20140139121A (ko) 2014-12-04
HK1111893A1 (zh) 2008-08-22
JP2014193926A (ja) 2014-10-09
HK1223024A1 (zh) 2017-07-21
KR101547925B1 (ko) 2015-08-27
US9585911B2 (en) 2017-03-07
US20180353536A1 (en) 2018-12-13
PT1924246E (pt) 2016-02-10
WO2007035313A3 (en) 2007-06-14
IL253711A0 (en) 2017-09-28
BRPI0616078A2 (pt) 2011-06-07
AU2006292672A1 (en) 2007-03-29
IL239617A (en) 2017-08-31
EP1924246A2 (en) 2008-05-28
US20160113961A1 (en) 2016-04-28
JP2009508580A (ja) 2009-03-05
CN101272762A (zh) 2008-09-24
US20170326172A1 (en) 2017-11-16
CA2622693A1 (en) 2007-03-29
WO2007035313A2 (en) 2007-03-29
BRPI0616078B8 (pt) 2021-05-25
PL1924246T3 (pl) 2016-04-29
JP6029736B2 (ja) 2016-11-24
JP2016047849A (ja) 2016-04-07
IL239617A0 (en) 2015-08-31
NZ566542A (en) 2011-06-30
CA2622693C (en) 2015-05-05
AU2006292672B2 (en) 2012-04-19
US9095509B2 (en) 2015-08-04
CN101272762B (zh) 2013-02-06
EP1924246B1 (en) 2015-10-21
SI1924246T1 (sl) 2016-01-29
JP5922184B2 (ja) 2016-05-24
IL189967A (en) 2015-07-30
US20070059277A1 (en) 2007-03-15
DK1924246T3 (en) 2016-01-18
EP3000460A1 (en) 2016-03-30
KR101574072B1 (ko) 2015-12-04
KR20080047458A (ko) 2008-05-28
IL189967A0 (en) 2008-08-07
ES2556217T3 (es) 2016-01-14
CN103027896B (zh) 2016-01-20
JP5595660B2 (ja) 2014-09-24
CN103027896A (zh) 2013-04-10
BRPI0616078B1 (pt) 2020-01-28

Similar Documents

Publication Publication Date Title
DK1924246T3 (en) PORTION LETTER DEFINITION OF amine polymers
EP1827386B1 (en) Oral compositions for absorption of phosphorus compounds
TWI312285B (en) Methods of treatment using a gastric retained gabapentin dosage
JP6263699B2 (ja) 不快味マスキング剤を有する水性薬物送達システム
KR960011772B1 (ko) 개선된 디데옥시 퓨린 뉴클레오사이드 경구 투여 제제
JP2002543107A (ja) 葉酸補給物
EP1894557B1 (en) Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore
US7199160B2 (en) Antiobestic agents and health foods
AU2012205214B2 (en) Formulation for Amine Polymers
JP2011068614A (ja) ビタミン製剤